← SynDRA
OMADACYCLINE
SynDRA canonical compound SYN0026487 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx |
| Mechanism of action | bacterial 30S ribosomal subunit inhibitor |
| Indication | pneumonia |
| Disease area | infectious disease |
Mechanisms of action (all sources)
- bacterial 30S ribosomal subunit inhibitor
Drug classes
- Tetracycline-class Antibacterial
ATC classes
Cross-references
Synonyms
- omadacycline tosylate
- nuzyra
- PTK 0796
- amadacycline
- BAY 73-6944
- BAY 73-7388
- MK-2764
- neopentyl aminomethylminocycline
- ZL 2401
- Omadaciclina
- Amadacycline
- UNII-090IP5RV8F
- 090IP5RV8F
- Omadacycline [USAN:INN]
- Omadacycline (USAN)
- AC1NUY3H
- Amadacycline methanesulfonate
- SCHEMBL152
- Omadacycline [USAN]
- PTK 0796;Amadacycline
- BAY-73-6944
- omadaciclina
- C29H40N4O7
- Omadacycline (Standard)
- OMADACYCLINE [MI]
- Omadacycline Impurity 42
- OMADACYCLINE [INN]
- OMADACYCLINE [WHO-DD]
- SCHEMBL1525961
- 9-neopentylaminomethylminocycline
- SCHEMBL17150976
- SCHEMBL20952297
- SCHEMBL29363116
- GTPL10839
- PTK-796
- PTK0796
- CHEBI:177758
- EX-A4252
Reported adverse events
- Alanine aminotransferase increased
- Aspartate aminotransferase
- Aspartate aminotransferase increased
- Constipation
- Headache
- Hypersensitivity
- Hypertension
- Insomnia
- Nausea
- Vomiting
- Infusion site reaction
- Infusion site extravasation
Look up OMADACYCLINE in the interactive SynDRA portal →